InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
82%
T+90 mean return
+4.6%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by STAHL NEIL, Vice-Président Exécutif. Insider active across 1 company, notably Regeneron Pharmaceuticals, INC.. Aggregated, 22 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €187k. History available since 25 February 2021. The latest transaction was filed on 16 December 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations22 total
304 shares@ US$730.810.5% of flowCommon StockSEC:0001968202-24-000141:0
466 shares@ US$787.000.8% of flowCommon StockSEC:0001968202-24-000138:0
500 shares0Common StockSEC:0001968202-24-000117:0
100 shares@ US$1,081.830.2% of flowCommon StockSEC:0001968202-24-000115:0
23,638 shares@ US$555.6727.6% of flowCommon StockSEC:0001968202-24-000113:0
1,020 shares0Common StockSEC:0001968202-24-000078:0
100 shares@ US$947.340.2% of flowCommon StockSEC:0001968202-24-000056:0
30,750 shares@ US$399.6625.6% of flowCommon StockSEC:0001968202-24-000054:0
809 shares@ US$843.791.4% of flowCommon StockSEC:0001883850-23-000090:0
400 shares0Common StockSEC:0001968202-23-000040:0
50,000 shares@ US$399.6641.6% of flowCommon StockSEC:0001968202-23-000023:0
1,101 shares0Common StockSEC:0001883850-22-000136:0
330 shares0Common StockSEC:0001883850-22-000119:0
335 shares0Common StockSEC:0001883850-22-000053:0
753 shares@ US$664.340.0006% mcap50.0% of flowCommon StockSEC:0001708138-21-000104:0
753 shares@ US$664.340.0006% mcap100.0% of flowCommon StockSEC:0001708138-21-000104
2,926 shares0Common StockSEC:0001708138-21-000093
2,926 shares0Common StockSEC:0001708138-21-000093:0
4,605 shares0Common StockSEC:0001883850-21-000018
4,605 shares0Common StockSEC:0001883850-21-000018:0
435 shares0Common StockSEC:0001708138-21-000020
435 shares0Common StockSEC:0001708138-21-000020:0
22 of 22 declarations
About STAHL NEIL
Neil Stahl is the Executive Vice President at REGENERON PHARMACEUTICALS, INC. He oversees the research and development of new treatments, playing a key role in the company's innovation. His expertise is essential for the success of research initiatives and for meeting patient needs.
